Page last updated: 2024-08-21

diphenyldiselenide and Candidiasis, Vulvovaginal

diphenyldiselenide has been researched along with Candidiasis, Vulvovaginal in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alves, SH; Cervi, VF; Cruz, L; Denardi, LB; Ferreira, LM; Nogueira, CW; Sari, MHM; Zimmermann, ES1

Other Studies

1 other study(ies) available for diphenyldiselenide and Candidiasis, Vulvovaginal

ArticleYear
Mucoadhesive gellan gum hydrogel containing diphenyl diselenide-loaded nanocapsules presents improved anti-candida action in a mouse model of vulvovaginal candidiasis.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021, Dec-01, Volume: 167

    Topics: Animals; Antifungal Agents; Benzene Derivatives; Candida; Candidiasis, Vulvovaginal; Female; Humans; Hydrogels; Mice; Nanocapsules; Organoselenium Compounds; Polysaccharides, Bacterial

2021